Xuefeng Gu

490 total citations
18 papers, 377 citations indexed

About

Xuefeng Gu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuefeng Gu has authored 18 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuefeng Gu's work include Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xuefeng Gu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers) and RNA modifications and cancer (4 papers). Xuefeng Gu collaborates with scholars based in China and Hong Kong. Xuefeng Gu's co-authors include Wenjun Zhang, Paul K. Chu, Teng Qiu, Wei Zhao, Lin Xiong, Liang Qiu, Jiang Li, Chuanbing Shi, Yuan Mao and Xiaojun Tang and has published in prestigious journals such as PLoS ONE, Scientific Reports and BioMed Research International.

In The Last Decade

Xuefeng Gu

15 papers receiving 372 citations

Peers

Xuefeng Gu

EOMM

Jiao Tan China

Fang‐Ming Chen Taiwan

Zhitao Chen China

Zhiyuan Zheng China

Baiwen Li China

Dawn R. Christianson United States

Takayuki Morimoto Japan

Peirong Xu China

Xuehong Zhang China

Jiao Tan China

Xuefeng Gu

130 ×0.7

23 ×0.3

EOMM

50 ×0.6

57 ×0.8

91 ×1.4

Citations per year, relative to Xuefeng Gu Xuefeng Gu (= 1×) peers Jiao Tan

Countries citing papers authored by Xuefeng Gu

Since Specialization

Citations

This map shows the geographic impact of Xuefeng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Gu more than expected).

Fields of papers citing papers by Xuefeng Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Gu. The network helps show where Xuefeng Gu may publish in the future.

Co-authorship network of co-authors of Xuefeng Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Gu. A scholar is included among the top collaborators of Xuefeng Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Gu. Xuefeng Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yang, Ning, et al.. (2025). Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients. BMC Infectious Diseases. 25(1). 151–151. 1 indexed citations

Gu, Xuefeng, et al.. (2025). Based on disulfidptosis, unveiling the prognostic and immunological signatures of Asian hepatocellular carcinoma and identifying the potential therapeutic target ZNF337-AS1. Discover Oncology. 16(1). 544–544. 1 indexed citations

Gu, Xuefeng, et al.. (2024). Systematic Analysis of Disulfidptosis-Related lncRNAs in Hepatocellular Carcinoma with Vascular Invasion Revealed That AC131009.1 Can Promote HCC Invasion and Metastasis through Epithelial–Mesenchymal Transition. ACS Omega. 9(50). 49986–49999.

Shi, Chuanbing, et al.. (2024). A New Cuproptosis-Related lncRNAs Model for Predicting the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Experimental Validation of LINC01269. International Journal of General Medicine. Volume 17. 6009–6027.

Gu, Xuefeng, et al.. (2024). Construction of a prognostic model for disulfidptosis-related long noncoding RNAs in R0 resected hepatocellular carcinoma and analysis of their impact on malignant behavior. BMC Cancer. 24(1). 1068–1068.

Gu, Xuefeng, et al.. (2021). Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19. Frontiers in Cellular and Infection Microbiology. 11. 654272–654272. 16 indexed citations

Gu, Xuefeng, et al.. (2020). Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor‐Node‐Metastasis Stage I Hepatocellular Carcinoma. BioMed Research International. 2020(1). 5831064–5831064. 7 indexed citations

Gu, Xuefeng, et al.. (2020). A prognostic model composed of four long noncoding RNAs predicts the overall survival of Asian patients with hepatocellular carcinoma. Cancer Medicine. 9(16). 5719–5730. 18 indexed citations

Gu, Xuefeng, Yuan Mao, Chuanbing Shi, et al.. (2019). <p>MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal Transition</p>. OncoTargets and Therapy. Volume 12. 7843–7855. 6 indexed citations

10.

Yang, Shu, Xuefeng Gu, Hongyu Shen, et al.. (2019). SPARC correlates with unfavorable outcome and promotes tumor growth in lung squamous cell carcinoma. Experimental and Molecular Pathology. 110. 104276–104276. 11 indexed citations

11.

Gu, Xuefeng, Chuanbing Shi, & Wei Zhao. (2019). Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.. PubMed. 12(6). 2173–2183. 7 indexed citations

12.

Gu, Xuefeng, et al.. (2019). CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis. PeerJ. 7. e7816–e7816. 12 indexed citations

13.

Gu, Xuefeng, Yuqin Ding, Wei Zhang, et al.. (2014). TIMP-3 Expression Associates with Malignant Behaviors and Predicts Favorable Survival in HCC. PLoS ONE. 9(8). e106161–e106161. 35 indexed citations

14.

Gu, Xuefeng, Zhijun Ge, Feng Zhan, et al.. (2014). High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma. Scientific Reports. 4(1). 6625–6625. 45 indexed citations

15.

Yang, Ju, Yajing Weng, Weifei Fan, et al.. (2014). High SHIP2 Expression Indicates Poor Survival in Colorectal Cancer. Disease Markers. 2014. 1–7. 20 indexed citations

16.

Fan, Weifei, Wei Zhang, Feng Chang, et al.. (2013). Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer.. PubMed. 6(10). 2185–91. 32 indexed citations

17.

Gu, Xuefeng, Wei Zhang, Feng Chang, et al.. (2013). High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.. PubMed. 6(11). 2515–22. 23 indexed citations

18.

Gu, Xuefeng, Teng Qiu, Wenjun Zhang, & Paul K. Chu. (2011). Light-emitting diodes enhanced by localized surface plasmon resonance. Nanoscale Research Letters. 6(1). 199–199. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact